Understanding Disease Through Biomarkers: Symposium Available On-Demand

Biomarkers are at the heart of modern biomedical research. From physiological measurements and small molecules to imaging and histologic information, these indicators reveal valuable insights into health and disease. They guide early detection, track disease progression, shape diagnostic and therapeutic decisions, and expand our understanding of complex biology.

That’s why Aviva partnered with The Scientist to sponsor the symposium “Understanding Disease Through Biomarkers.” Now available to watch on our YouTube channel, the event brings together industry and academic experts who share how they are uncovering novel biomarkers across oncology, neurology, and autoimmune disease.

Who You’ll Hear From

• Jorge Moscat, PhD​​ - p62 and NBR1: Balancing Tumor Promotion and Immune Activation in HCC​
• Katie Irwin, MD-PhD Candidate​​ - A Novel Fluid Biomarker Reveals TDP-43 Dysfunction in Presymptomatic ALS-FTD​
• Francesca I. De Simone, PhD​​ - The Evolution of AD Diagnosis: The Role of Biomarkers​
• Luis Alvarez - ​​3D High-Multiplex Imaging in Cancer Immunology​
• Lisa Willis, PhD - Scleroderma: Sex Differences in Immune Sugars Point to Potential New Diagnostics

What You’ll Learn

By watching the symposium, you’ll gain:

• A broad survey of emerging biomarker strategies from fluid-based assays to multiplex imaging and molecular profiling.
• Insights into the latest disease applications including cancer, neurodegenerative disease, and systemic autoimmune disorders.
• Perspectives on clinical translation and how researchers are moving biomarkers from discovery into diagnostic tools and precision therapies.
• Examples of innovative technologies driving biomarker sensitivity, specificity, and reproducibility.

The program underscores how quickly the biomarker landscape is evolving, and how essential robust reagents and validated platforms are for progress. At Aviva, we’re proud to contribute by supplying researchers with high-performance recombinant antibodies and assays that meet the rigorous demands of today’s biomarker discovery.

The full “Understanding Disease Through Biomarkers” symposium is available now on our YouTube channel. Whether you’re exploring new biomarkers in your own work or staying current on where the field is headed, this on-demand event offers insights you won’t want to miss.

Watch the Symposium Replay on YouTube

With the demand for reliable, highly specific reagents required for sensitive biomarker detection, Aviva is incredibly proud to offer cutting edge recombinant antibodies that can power biomarker detection with the highest sensitivity. Inquire today to see how we can power your research projects.

We Have Your Target Covered.